1.0
12 Aug 2015
Former employee, more than 3 years
Dallas, TX
Recommend
CEO approval
Business outlook
Pros
A division of Novartis, a great company, although movement between divisions is difficult
Cons
Leadership is largely absent Lacks innovation Business results unsteady at beast